Sabatelli, Mario
 Distribuzione geografica
Continente #
EU - Europa 7.598
NA - Nord America 7.312
AS - Asia 2.132
AF - Africa 79
SA - Sud America 21
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 17.169
Nazione #
US - Stati Uniti d'America 7.225
DE - Germania 2.897
SE - Svezia 1.240
CN - Cina 978
UA - Ucraina 698
IT - Italia 626
SG - Singapore 552
PL - Polonia 527
GB - Regno Unito 412
IE - Irlanda 352
FR - Francia 306
ID - Indonesia 216
FI - Finlandia 186
RU - Federazione Russa 154
IN - India 128
TR - Turchia 97
CA - Canada 80
BE - Belgio 75
CI - Costa d'Avorio 44
NL - Olanda 38
JP - Giappone 35
ZA - Sudafrica 31
HK - Hong Kong 27
CH - Svizzera 23
KR - Corea 23
VN - Vietnam 21
IR - Iran 19
AU - Australia 18
RO - Romania 13
PH - Filippine 11
ES - Italia 10
BR - Brasile 8
CL - Cile 6
CZ - Repubblica Ceca 6
EU - Europa 6
GR - Grecia 6
AE - Emirati Arabi Uniti 4
HR - Croazia 4
NO - Norvegia 4
SA - Arabia Saudita 4
AR - Argentina 3
DK - Danimarca 3
LK - Sri Lanka 3
MX - Messico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BZ - Belize 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
PE - Perù 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AL - Albania 1
BD - Bangladesh 1
BY - Bielorussia 1
DZ - Algeria 1
EC - Ecuador 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 17.169
Città #
Chandler 1.310
Ashburn 481
Warsaw 468
Singapore 437
Dublin 344
Jacksonville 332
Ann Arbor 322
San Mateo 317
Redmond 284
Nanjing 261
New York 225
Nürnberg 219
Wilmington 218
Jakarta 213
Fairfield 199
Woodbridge 174
Houston 164
Boston 160
Seattle 139
Cattolica 136
Dearborn 129
Lawrence 113
Moscow 113
Nanchang 112
Milan 100
Redwood City 93
Izmir 86
Beijing 83
Chicago 77
Munich 71
Princeton 71
Marseille 67
Detroit 61
Cambridge 59
Bremen 56
Brussels 56
Kraków 53
Rome 52
Norwalk 49
Shenyang 48
Abidjan 44
Los Angeles 44
Hebei 42
Jiaxing 39
University Park 39
Leawood 38
Boardman 37
London 37
Mountain View 36
Changsha 35
Hangzhou 33
Guangzhou 31
Kunming 31
Ottawa 30
Tianjin 28
Helsinki 27
Philadelphia 27
Zhengzhou 27
Fremont 25
Pune 25
Lappeenranta 24
Seoul 23
Lancaster 22
Phoenix 22
Simi Valley 22
Santa Clara 18
Hong Kong 16
Waanrode 16
Auburn Hills 14
Hefei 14
Las Vegas 14
Birmingham 13
Cape Town 13
Edinburgh 13
Hanoi 13
Toronto 13
Paris 12
Shanghai 12
Ningbo 11
San Diego 11
San Jose 11
Buffalo 10
Changchun 10
Greensboro 10
Jinan 10
Millbury 10
Nashville 10
Padova 10
Chengdu 9
Dallas 9
Falls Church 9
Frankfurt am Main 9
Leeds 9
Washington 9
Augusta 8
Busto Arsizio 8
Manchester 8
Miami 8
Monza 8
The Bronx 8
Totale 9.126
Nome #
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early-access program in Italy 677
Clinical–neurophysiological correlations in a series of patients with IgM-related neuropathy 323
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients 321
Natural History of Young-Adult Amyotrophic Lateral Sclerosis. 303
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 263
Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS) 215
Teaching neuroimages: Peroneal intraneural ganglion cyst: a rare cause of drop foot in a child. 204
A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia 198
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 197
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 195
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 191
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 181
Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers 172
Retinal detachment with an unusual shape. 168
Replication of association of CHRNA4 rare variants with sporadic amyotrophic lateral sclerosis: The Italian multicentre study 165
Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease 163
Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? 136
Abnormal vascular smooth muscle cell proliferation in sural nerve biopsy from a patient with sensorimotor axonal neuropathy. 134
Chronic GM2 gangliosidosis type Sandhoff associated with a novel missense HEXB gene mutaton causing a double patogenetic effect 134
D11Y SOD1 mutation and benign ALS: a consistent genotype-phenotype correlation 132
Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS 130
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 128
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 120
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 119
Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience 117
Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis. 116
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 114
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 114
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene 113
Clinical, neurophysiological and pathological findings of HNPP patients with 17p12 deletion: A single-centre experience 113
Mechanically assisted cough in amyotrophic lateral sclerosis: Effect on vital capacity decline and timing of non invasive ventilation onset 113
A new single-nucleotide deletion of PMP22 in an HNPP family without recurrent palsies. 112
Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study 110
Classification of familial amyotrophic lateral sclerosis by family history: effects on frequency of genes mutation 108
Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. 108
New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis 108
Clinical, neurophysiological and pathological findings of HNPP patients with 17p12 deletion: a single-centre experience 107
Admission neurophysiological abnormalities in Guillain-Barré syndrome: A single-center experience 107
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 105
SOD1 G93D mutation presenting as paucisymptomatic amyotrophic lateral sclerosis. 104
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 103
Ultrasound evaluation in transthyretin-related amyloid neuropathy 103
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 103
Matrin 3 variants are frequent in Italian ALS patients 103
A novel L67P SOD1 mutation in an Italian ALS patient. 102
A useful electrophysiological test for diagnosis of minimal conduction block 102
Is it the use of Non Invasive Ventilation for less than four hours in the day sufficient to prolong survival in patients with Amyotrophic Lateral Sclerosis? 101
ATXN2 polyQ intermediate repeats are a modifier of ALS survival 101
A Genome-wide Association Study of Myasthenia Gravis 101
Neurologic improvement after peripheral blood stem cell transplantation in poems 98
Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy 98
SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant 97
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 97
Usefulness of F-18 FDG PET/CT in the follow-up of POEMS syndrome after autologous peripheral blood stem cell transplantation 96
Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy 96
Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis. 96
P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis 95
Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia. 95
Classification of familial amyotrophic lateral sclerosis by family history: effects on frequency of genes mutation 93
Triple A syndrome: a novel compound heterozygous mutation in the AAAS gene in an Italian patient without adrenal insufficiency. 92
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 92
ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis 92
Teaching NeuroImages: cochleitis: a rare cause of acute deafness in a patient with HCV 91
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 91
Wernicke's encephalopathy following chronic diarrhoea 91
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 91
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 91
SOD1 p.D12Y variant is associated with ALS/distal myopathy spectrum 91
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 90
Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9ORF72 expansion 90
Long-term motor cortex stimulation for amyotrophic lateral sclerosis 90
Neuropathy with predominant small fiber involvement associated with abnormal anti-MAG titer. 88
Teaching NeuroImage: MRI of diabetic lumbar plexopathy treated with local steroid injection. 88
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients 88
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 88
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4. 87
Pure motor chronic inlammatory demyelinating polyneuropathy 86
A novel HSPB1 mutation in an Italian patient with CMT2/dHMN phenotype. 86
Founder effect hypothesis of D11Y SOD1 mutation in Italian amyotrophic lateral sclerosis patients 86
Nerve ultrasound in CMT2E/CMT1F due to NEFL mutation: Confirmation of an axonal pathology 86
ALS skin fibroblasts reveal oxidative stress and ERK1/2-mediated cytoplasmic localization of TDP-43 85
HFE p.H63D polymorphism does not influence ALS phenotype and survival 84
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 84
Coexistence of variants in TBK1 and in other ALS-related genes elucidates an oligogenic model of pathogenesis in sporadic ALS 84
Sural nerve pathology in ALS patients: a single-centre experience 83
Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration. 82
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 80
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 80
Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. 78
Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection 78
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 77
Clinical, electrophysiological and pathological findings of a patient with CMT2 due to the p.Ala738Val mitofusin 2 mutation. 76
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 76
ANCA-related vasculitic neuropathy mimicking motor neuron disease. 75
Peripheral neuropathy and 46XY gonadal dysgenesis: Confirmation of a heterogeneous entity 75
Nerve ultrasound in patients with CMT1C: Description of three cases 75
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72 74
Teaching NeuroImages: cochleitis: a rare cause of acute deafness in a patient with HCV 74
Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience 74
Gadolinium enhancement of the lumbar leptomeninges and roots in a case of ALS 73
Totale 12.060
Categoria #
all - tutte 68.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.525 0 0 0 0 193 234 260 93 139 171 246 189
2020/20211.624 79 169 65 178 226 89 189 38 191 110 261 29
2021/20221.841 185 146 27 207 62 57 49 260 99 90 298 361
2022/20234.304 452 545 323 515 284 453 156 273 422 732 87 62
2023/20241.807 81 567 48 111 65 308 94 63 11 89 164 206
2024/2025941 100 111 283 186 261 0 0 0 0 0 0 0
Totale 17.442